Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.36 USD | -5.45% | -6.07% | +114.64% |
07/05 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
06/05 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+114.64% | 626M | |
+18.63% | 47.02B | |
+48.77% | 41.86B | |
+0.40% | 41.76B | |
-4.27% | 28.8B | |
+11.81% | 26.05B | |
-22.16% | 19.15B | |
+4.35% | 12.55B | |
+28.53% | 12.34B | |
-3.92% | 11.82B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- BofA Securities Upgrades Stoke Therapeutics to Neutral From Underperform, Adjusts Price Target to $12 From $9